10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 312,514 | 588,475 | 600,468 | 640,109 | 635,359 |
| Marketable Securities | 226,836 | N/A | N/A | N/A | N/A |
| Receivables | 76,526 | 85,254 | 78,430 | 59,680 | 57,408 |
| Inventories | 63,697 | 59,966 | 51,141 | 44,087 | 38,507 |
| TOTAL | $697,335 | $747,591 | $744,104 | $757,174 | $745,716 |
| Non-Current Assets | |||||
| PPE Net | 190,200 | 169,492 | 142,589 | 122,329 | 107,313 |
| Intangibles | 29,275 | 29,908 | 4,511 | 4,511 | 4,511 |
| Other Non-Current Assets | 86,441 | 71,835 | 99,368 | 93,565 | 96,493 |
| TOTAL | $305,916 | $271,235 | $246,468 | $220,405 | $208,317 |
| Total Assets | $1,003,251 | $1,018,826 | $990,572 | $977,579 | $954,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,956 | 17,351 | 17,037 | 16,181 | 15,578 |
| Accrued Expenses | 62,419 | 82,535 | 73,369 | 86,766 | 94,334 |
| TOTAL | $94,446 | $110,357 | $100,375 | $113,126 | $120,549 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,434 | 5,340 | 5,505 | 5,274 | 4,481 |
| Other Non-Current Liabilities | 102,120 | 90,901 | 89,976 | 79,867 | 81,024 |
| TOTAL | $102,120 | $90,901 | $89,976 | $79,867 | $81,024 |
| Total Liabilities | $196,566 | $201,258 | $190,351 | $192,993 | $201,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,372 | 112,845 | 111,708 | 110,886 | 109,799 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -905,734 | -863,321 | -844,872 | -827,701 | -816,649 |
| Other shareholders' equity | -2,443 | 22 | 194 | 58 | 48 |
| TOTAL | $806,685 | $817,568 | $800,221 | $784,586 | $752,460 |
| Total Liabilities And Equity | $1,003,251 | $1,018,826 | $990,572 | $977,579 | $954,033 |